Panagiotis Drakopoulos

Universitair Ziekenhuis Brussel

Papers

1

Total Citations

84

H-Index

1

About

Panagiotis Drakopoulos is a leading figure in gynecologic oncology, with a research focus on sentinel lymph node mapping, minimally invasive surgery, and the optimization of surgical techniques for endometrial and cervical cancers. His most cited work, a 2019 randomized controlled trial comparing indocyanine green (ICG) with methylene blue for sentinel lymph node detection in endometrial cancer, demonstrated the superior efficacy of ICG, fundamentally shifting clinical practice toward fluorescence-based mapping. This landmark study, with 84 citations, has been instrumental in reducing the morbidity associated with lymphadenectomy and improving staging accuracy. Beyond this, Drakopoulos has contributed to the development of robotic-assisted surgical protocols and the integration of molecular classification into treatment planning. His work is characterized by rigorous methodology and a patient-centered approach, bridging the gap between surgical innovation and real-world outcomes. A sought-after speaker and educator, he continues to shape the next generation of gynecologic oncologists, driving progress in precision surgery and personalized cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
84
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer
84 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Universitair Ziekenhuis Brussel

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago